PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life: The purpose of this study is to find out more about how exposures during pregnancy , such as having an infection, diet, and growth may impact later risk of developing type 1 diabetes (T1D) and islet autoimmunity in the child.
Jan 2024: We are relocating to a different suite at St. Mary's
The BDC is the first center in Colorado to offer a newly approved drug meant to delay the onset of stage-3 Type 1 diabetes.
An annual conference reviewing the latest in diabetes screening, prevention, and treatments breakthroughs
The Barbara Davis Center provides state-of the-art care to children and adults with type 1 diabetes and teaches our patients how to prevent or delay complications. Our research is devoted to finding prevention, cure, and most effective treatment of diabetes and associated disorders.
Marian Rewers, MD, PhD
Type 1 diabetes makes you need insulin to stay healthy. Getting diagnosed with type 1diabetes can be a surprise, so it's good to know the signs to look out for. Learn more about type 1 diabetes, what symptoms to be aware of, and when it's important to see your doctor.
If someone in your family has type 1 diabetes, you and your blood-related family members have a 15-times higher chance of getting it too. Doing a simple blood test can tell you if you might develop type 1 diabetes. Most of the people we see in the clinic don't have a family member with type 1 diabetes, so even if your family doesn't have it, it's still important to check for it. Various programs and options are available depending on your circumstances, with convenient options at the BDC and in your community.
In 2022, the FDA gave the green light for a new treatment designed to postpone the need to start insulin in type 1 diabetes. This treatment is for people who are currently in stage 2 of type 1 diabetes, which means they show no symptoms but have diabetes-related autoantibodies and are starting to have abnormal blood sugar levels. Our clinic evaluates patients for this infusion therapy and offers treatment as part of its state-of-the-art clinical immunotherapy program.